Entity Address City Or Town Entity Address, City or Town Net Income Loss Available To Common Stockholders Basic Net loss attributable to common stockholders - basic Net loss attributable to common stockholders - basic Fair Value Disclosures [Abstract] Clinical trial. Clinical Trial [Member] Clinical Trial [Member] Class of warrant or right issued. Class Of Warrant Or Right Issued Warrant issued Earnings Per Share [Abstract] Fair Value Inputs Level1 [Member] Quoted Prices (Unadjusted) in Active Markets Level 1 [Member] Paid In Kind Interest Non-cash interest expense Stock Issued During Period Value New Issues Common stock issued at fair value Net Cash Provided By Used In Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Fair Value Disclosure Item Amounts [Domain] Fair Value Measurement Amendment Flag Amendment Flag Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value Weighted average grant date fair value per share Subsequent Event Type [Domain] Research And Development [Abstract] Significant Risks and Uncertainties Significant Risks And Uncertainties Policy [Text Block] Disclosure of accounting policy for Significant risks and uncertainties. Additional default interest rate. Additional Default Interest Rate Default interest rate Operating Lease Right Of Use Asset Right-of-use asset, net Document Quarterly Report Document Quarterly Report Debt Instrument [Table] Debt Instrument [Table] Offering price Offering Price Per Share Offering price per share. Upfront payments to be returned upon termination of agreement. Upfront Payments To Be Returned Upon Termination Of Agreement Upfront payments returned upon termination of agreement Statement [Table] Statement [Table] Operating Lease Liability Noncurrent Right-of-use liability, less current portion UCB license agreement. Ucb License Agreement [Member] UCB License Agreement [Member] Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value Fair value of restricted stock units vested Stock Issued During Period Shares Employee Stock Purchase Plans Stock purchase under ESPP, shares Number Of Operating Segments Number of operating segments Preferred Stock Shares Outstanding Preferred stock, shares outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Common Stock Capital Shares Reserved For Future Issuance Shares available for issuance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Unvested, Beginning balance Weighted Average Grant Date Fair Value, Unvested, Beginning balance Weighted Average Grant Date Fair Value, Unvested, Ending Balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Vested Reimbursable costs. Reimbursable Costs Reimbursable costs Nature Of Operations Nature of Business Insider Trading Arr [Abstract] Insider Trading Arr [Abstract] Prepayment Fee Prepayment Fee Business Combination, Contingent Consideration, Liability, Total Business Combination, Contingent Consideration, Liability Contingent liabilities Employee Related Liabilities Current Accrued compensation and related costs Employee-related Liabilities, Current, Total Trd Arr Securities Agg Avail Amt Trd Arr Securities Agg Avail Amt Trd Arr Securities Agg Avail Amt Employee Stock Option [Member] Options to Purchase Common Stock [Member] Stock options [Member] Liabilities And Stockholders Equity Total liabilities and stockholders’ equity Plan Name [Domain] Plan Name Line Of Credit Facility Lender [Domain] Line of Credit Facility, Lender Weighted Average Number Of Shares Outstanding [Abstract] Denominator—basic and diluted: Entity Incorporation State Country Code Entity Incorporation, State or Country Code State of incorporation Income Statement [Abstract] Remaining contractual obligation. Remaining Contractual Obligation Remaining contractual obligation Weighted Average Grant Date Fair Value, Vested and exercisable, end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Non Us [Member] Ex-U.S. Countries [Member] Proceeds From Stock Plans Proceeds from Employee Stock Purchase Plan Derivative Liabilities Derivative liability Derivative Liability, Total Percentage of prepayment premium of principal amount outstanding thereafter. Percentage Of Prepayment Premium Of Principal Amount Outstanding Thereafter Percentage of prepayment premium of principal amount outstanding thereafter prior to maturity date Sale Of Stock Name Of Transaction [Domain] Sale of Stock Two thousand and twenty two performance awards. Two Thousand And Twenty Two Performance Awards [Member] 2022 Performance Awards [Member] Liabilities Current Total current liabilities Upfront payments received. Upfront Payments Received License agreement upfront payment received Reimbursable expense due from counterparty. Reimbursable Expense Due From Counterparty Reimbursable expense due from counterparty Stock Issued During Period Value Employee Stock Purchase Plan Stock purchase under ESPP Earnings Per Share Basic [Line Items] Earnings Per Share Basic [Line Items] Line of credit facility minimum cash covenant waived. Line Of Credit Facility Minimum Cash Covenant Waived Minimum cash covenant waived Interest Expense Interest expense Interest Expense, Total Increase Decrease In Contract With Customer Liability Deferred revenue US Treasury and Government [Member] US Treasury and Federal bonds [Member] Employee service share based compensation recognized stock options not met. Employee Service Share Based Compensation Recognized Stock Options Not Met Recognized compensation expense related to stock option not met Preferred Stock Shares Authorized Preferred stock, shares authorized Deposits Assets Current Short-term deposits Type Of Revenue Extensible List Type of revenue [extensible list] Variable Rate [Axis] Variable Rate Commercial Paper Not Included With Cash And Cash Equivalents [Member] Commercial Paper [Member] Entity Small Business Entity Small Business Type Of Arrangement [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Current portion of capital lease. Current Portion Of Capital Lease Current portion of capital lease Assets Current Total current assets Two thousand seven and two thousand fifteen stock incentive plan. Two Thousand Seven And Two Thousand Fifteen Stock Incentive Plan [Member] 2015 and 2007 [Member] Weighted Average Number Of Shares Outstanding Basic Weighted-average number of common shares used to compute net loss per share attributable to common stockholders —basic Weighted-average number of common shares used to compute net loss per share attributable to common stockholders—basic Weighted Average Number of Shares Outstanding, Basic, Total City Area Code City Area Code Business Description And Basis Of Presentation [Text Block] Basis of Presentation Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Share-based compensation, stock options cancelled Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Liabilities Total liabilities Private Placement [Member] Private Placement [Member] Document Period End Date Document Period End Date Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Weighted average grant date fair value of options Available For Sale Debt Securities Amortized Cost Basis Amortized Cost Range [Axis] Statistical Measurement Debt instrument tranche two Debt Instrument Tranche Two [Member] Tranche 2 [Member] Proceeds From Sale And Maturity Of Available For Sale Securities Proceeds from sales and maturities of short-term investments Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total Assets Total assets Capital lease, less current portion. Capital Lease Less Current Portion Capital lease, less current portion Schedule Of Earnings Per Share Basic By Common Class [Table] Schedule Of Earnings Per Share Basic By Common Class [Table] Earnings Per Share Diluted Net loss per share attributable to common stockholders—diluted Net loss per share attributable to common stockholders— diluted Earnings Per Share, Diluted, Total Hercules Capital, Inc. Hercules Capital Inc [Member] Hercules [Member] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Potential Dilutive Securities Excluded from Computation of Diluted Net Loss per Common Share Dividends Deemed dividend due to warrant reset Dividends, Total Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Ending Balance 6/30/22 Beginning Balance 12/31/21 Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract] Entity Address Postal Zip Code Entity Address, Postal Zip Code Document Fiscal Period Focus Document Fiscal Period Focus Preferred stock, $0.001 par value, 10,000,000 shares authorized; 0 shares outstanding at June 30, 2023 and December 31, 2022 Preferred Stock Value Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total Investment Income Interest Interest income Repurchase Agreement Counterparty Name [Domain] Counterparty Name Revenue recognized upon transfer of license agreement. Revenue Recognized Upon Transfer Of License Agreement Revenue recognized upon transfer of license agreement Net Cash Provided By Used In Financing Activities Net cash provided by financing activities Share based compensation arrangement by share based payment award stock option grant date fair value. Share Based Compensation Arrangement By Share Based Payment Award Stock Option Grant Date Fair Value Options grant date fair value amount Incyte corporation. Incyte Corporation [Member] Incyte Corporation [Member] Prepaid conference, meeting costs Prepaid Conference, Meeting Costs Prepaid conference, meeting costs Statement Of Financial Position [Abstract] Entity File Number Entity File Number Scenario Unspecified [Domain] Scenario Statement Of Cash Flows [Abstract] Upfront payments. Upfront Payments Upfront milestone payable Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants issued (in shares) Segment Geographical [Domain] Geographical Range [Member] Statistical Measurement Accrued Research And Development Costs Accrued Research And Development Costs Accrued research and development costs Subsidiary Sale Of Stock [Axis] Sale of Stock Legal Entity [Axis] Legal Entity Stock issued during period value at the market offering net. Stock Issued During Period Value At The Market Offering Net Proceeds from ATM sales Significant agreements disclosure. Significant Agreements Disclosure [Text Block] Significant Agreements Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Stock option granted to certain executives, consultants and employees Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total Proceeds From Stock Options Exercised Proceeds from stock option exercises Proceeds from issuance of common stock in follow-on public stock offering, net Proceeds from issuance of common stock in at-the-market stock offering, net Proceeds from issuance of common stock Mtrl Terms of Trd Arr 1 [Text Block] Mtrl Terms of Trd Arr 1 [Text Block] Mtrl Terms of Trd Arr 1 [Text Block] Disclosure Of Share Based Compensation Arrangements By Share Based Payment Award [Text Block] Compensation Expense by Type of Award Employees. Employees [Member] Employees [Member] Federal bonds. Federal Bonds [Member] Federal Bonds [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities Depreciation and related adjustment. Depreciation And Related Adjustment Depreciation Line Of Credit Facility Maximum Borrowing Capacity Aggregate maximum borrowings Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block] Schedule of Common Stock Reserved for Future Issuance Preferred Stock Par Or Stated Value Per Share Preferred stock, par value Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Unrealized Gains Number Of Pre Funded Warrants Exercised For Common Stock Number Of Pre Funded Warrants Exercised For Common Stock Number of pre funded warrants exercised for common stock Credit Facility [Domain] Credit Facility Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] Weighted Average Number Of Diluted Shares Outstanding Weighted-average number of common shares used to compute net loss per share attributable to common stockholders—diluted Weighted-average number of common shares used to compute net loss per share attributable to common stockholders—diluted Weighted Average Number of Shares Outstanding, Diluted, Total Credit Facility [Axis] Credit Facility Corporate Debt Securities [Member] Corporate Bonds [Member] Portion at Fair Value Measurement [Member] [Default] Portion at Fair Value Measurement [Member] General And Administrative Expense [Member] General and Administrative [Member] Stock issued during period shares at the market offering net. Stock Issued During Period Shares At The Market Offering Net Proceeds from ATM sales, shares Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Share based compensation Trd Arr Termination Date Trd Arr Termination Date Trd Arr Termination Date Current Fiscal Year End Date Current Fiscal Year End Date Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CASH, CASH EQUIVALENTS AND RESTRICTED CASH —end of period CASH, CASH EQUIVALENTS AND RESTRICTED CASH—beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Other Assets Noncurrent Other assets Entity Address Address Line1 Entity Address, Address Line One Interest Receivable Current Interest receivable on investments Supplemental Cash Flow Information [Abstract] SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cowen and Company LLC. Cowen And Company L L C [Member] Cowen and Company LLC [Member] Restricted Cash, Noncurrent Restricted cash Prepaid Subscriptions Prepaid Subscriptions Prepaid subscriptions Other Accrued Liabilities Current Other Stock Issued During Period Shares New Issues Common stock shares purchased Common stock, new shares issued Carrying Reported Amount Fair Value Disclosure [Member] Carrying Value [Member] Two thousand and nineteen performance awards. Two Thousand And Nineteen Performance Awards [Member] 2019 Performance Awards [Member] Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Schedule Of Research And Development Arrangement Contract To Perform For Others [Table] Schedule Of Research And Development Arrangement Contract To Perform For Others [Table] Equity [Abstract] Operating Income Loss Loss from operations Debt Instrument Interest Rate Stated Percentage Interest rate Accrued milestone costs Accrued milestone costs Accrued Milestone Costs Liabilities Noncurrent Total long-term liabilities Additional Paid In Capital Common Stock Additional paid-in capital Statement Scenario [Axis] Scenario Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Gross proceeds from offering Gross Proceeds From Offering Gross proceeds from offering. Accrued Professional Fees Current Accrued professional fees Accrued Liabilities And Other Liabilities Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Entity Filer Category Entity Filer Category Liabilities Noncurrent [Abstract] Long-term liabilities: Operating Expenses Total operating expenses Entity Current Reporting Status Entity Current Reporting Status Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain] Asset Class Milestone Expenses Paid Milestone Expenses Paid Schedule Of Accounts Payable And Accrued Liabilities Table [Text Block] Schedule of Accrued Expenses and Other Current Liabilities Prime Rate [Member] Wall Street Journal Prime Rate [Member] All Trading Arrangement [Member] All Trading Arrangement [Member] Stockholders Equity Note Disclosure [Text Block] Stockholders' Equity Stockholders Equity Ending balance Beginning balance Total stockholders’ equity Debt Securities Available For Sale Realized Gain Loss Realized gains or losses recognized on the sale or maturity of available-for-sale securities Debt Securities, Available-for-Sale, Realized Gain (Loss), Total Accumulated Other Comprehensive(Loss) / Income [Member] Accumulated Other Comprehensive Income [Member] Fair Value By Asset Class [Axis] Asset Class Entity Tax Identification Number Entity Tax Identification Number Income Statement Location [Axis] Income Statement Location Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Share-based compensation, stock options net of cancellations Number of Shares, Forfeited Common stock, $0.0001 par value, 100,000,000 shares authorized; 69,431,198 and 68,111,385 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively Common Stock Value Retained Earnings Accumulated Deficit Accumulated deficit Retained Earnings (Accumulated Deficit), Total Statement Equity Components [Axis] Equity Components Derivative, Gain (Loss) on Derivative, Net, Total Derivative, Gain (Loss) on Derivative, Net Changes in fair value of derivative liability Changes in fair value of derivative liability Percentage of end of term charge to future draws. Percentage Of End Of Term Charge To Future Draws Percentage of end of term charge to future draws Exercise Of Prefunded Warrants, Shares Exercise of prefunded warrants shares. Prefunded warrants, exercise, shares Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Text Block] Schedule of Prepaid Expenses and Other Current Assets Payments To Acquire Short Term Investments Purchases of short and long-term investments Entity Emerging Growth Company Entity Emerging Growth Company Related Party Transaction [Axis] Related Party Transaction Operating Expenses [Abstract] Operating expenses: Proceeds from sales of equipment Proceeds from Sale of Machinery and Equipment Interest Expense Debt Interest expense related to the loan agreement Interest Expense, Debt, Total Other Current Assets [Text Block] Prepaid Expenses and Other Current Assets Number of shares, Vested and exercisable, end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Term loan. Term Loan [Member] Term Loan [Member] Debt Securities Available For Sale [Table] Debt Securities Available For Sale [Table] Insider Trading Arr [Line Items] Insider Trading Arr [Line Items] Document Transition Report Document Transition Report Assets Fair Value Disclosure Total assets Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Granted Total other income (expense), net Nonoperating Income Expense Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block] Accrued Expenses and Other Current Liabilities Line Of Credit Facility Interest Rate Description Interest rate description Commitments And Contingencies Disclosure [Text Block] Commitments and Contingencies Weighted Average Grant Date Fair Value, Exercised/Released Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Research And Development Arrangement Contract To Perform For Others [Line Items] Research And Development Arrangement Contract To Perform For Others [Line Items] License agreements expiration period. License Agreements Expiration Period License expiration year Vesting of Restricted Stock Units, Shares Vesting of Restricted Stock Units, Shares Vesting of RSU, shares Trading Arr By Ind1 [Table] Trading Arr By Ind1 [Table] Net Income Loss Net loss Net loss Collaboration payable, net Collaboration Payable, Current Collaboration Payable, Current Collaboration receivable Collaboration receivable Collaboration receivable, net Collaboration receivable Fair Value Measurement Inputs Disclosure [Text Block] Fair Value Measurements Operating Lease Liability Current Current portion of right-of-use liability Warrant, Down Round Feature, Decrease in Net Income to Common Shareholder, Amount Deemed dividend due to warrant reset Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block] Schedule of Fair Values of Financial Assets and Liabilities Measured at Fair Value Additional Paid In Capital [Member] Additional Paid-In Capital [Member] Arrangements And Nonarrangement Transactions [Member] Collaborative Arrangement and Arrangement Other than Collaborative Scenario two. Scenario Two [Member] Available through November 30, 2022 [Member] Schedule Of Maturities Of Long Term Debt Table [Text Block] Summary of Maturities of Principal Obligations Under Long-term Debt Debt instrument, tranche three. Debt Instrument Tranche Three [Member] Tranche 3 [Member] Entity Registrant Name Entity Registrant Name Liabilities Fair Value Disclosure Total liabilities Cash And Cash Equivalents At Carrying Value Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Earnings Per Share [Text Block] Net Loss per Share Attributable to Common Stockholders Trd Arr Ind Title Trd Arr Ind Title Trd Arr Ind Title Share Based Compensation Stock-based compensation Share-Based Payment Arrangement, Noncash Expense, Total Milestone payment due. Milestone Payment Due Milestone payment payable Property Plant And Equipment Net Property and equipment, net Property, Plant and Equipment, Net, Total Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Award Type Statement [Line Items] Statement [Line Items] First amendment to loan and security agreement. First Amendment To Loan And Security Agreement [Member] First Amendment to Loan Agreement [Member] License agreement. License Agreement [Member] License Agreement [Member] Security12b Title Title of 12(b) Security Increase Decrease In Accounts Payable Accounts payable Increase (Decrease) in Accounts Payable, Total Liability related to letter agreement. Liability Related To Letter Agreement Liability related to letter agreement Derivative Liabilities [Abstract] Derivative Liability: Common Stock [Member] Common Stock [Member] Pre-Payment Fees Payments for Other Fees Net Cash Provided By Used In Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Equity Component [Domain] Equity Component Revenue From Contract With Customer Excluding Assessed Tax Total revenues Total revenues Entity Address State Or Province Entity Address, State or Province Contractual Obligation Aggregate payment obligation Contractual Obligation, Total Statement Geographical [Axis] Geographical NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Document Type Document Type Interest Paid Net Cash paid for interest Collaboration expense due to counterparty. Collaboration Expense Due To Counterparty Collaboration expense due to counterparty Development costs associated with clinical trials. Development Costs Associated With Clinical Trials Development costs associated with clinical trials Entity Shell Company Entity Shell Company Class Of Warrant Or Right Outstanding Warrants Outstanding All Individual [Member] All Individual [Member] Allocated Share Based Compensation Expense Share based compensation expense, total Accumulated other comprehensive (loss) Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Security Exchange Name Security Exchange Name Class Of Stock [Line Items] Class Of Stock [Line Items] Class of Stock [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Net Cash Provided By Used In Operating Activities Net cash used in operating activities Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Weighted average period to recognize compensation expense Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Other comprehensive loss: Commitments And Contingencies Disclosure [Abstract] Trd Arr Ind Name Trd Arr Ind Name Trd Arr Ind Name Restricted Stock Units R S U [Member] Non-Vested Restricted Stock Units (RSUs) [Member] Restricted Stock Units [Member] Payment on term loan Prepayment of loan Payments for (Proceeds from) Deposit on Loan Warrant [Member] Warrant [Member] Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block] Summary of Restricted Stock Units Activity Prefunded warrants, exercise Adjustment of Warrants Granted for Services Employee stock purchase plan. Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan [Member] New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued and Adopted Accounting Pronouncements Common Stock Shares Outstanding Common stock, shares outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Accretion Amortization Of Discounts And Premiums Investments Accretion of investments Debt Disclosure [Text Block] Loan Payable Fair Value Inputs Level2 [Member] Significant Other Observable Inputs Level 2 [Member] Available For Sale Securities Debt Securities Fair Value Debt Securities, Available-for-Sale, Total Net Cash Provided By Used In Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Contractual obligations term. Contractual Obligations Term Period of contractual obligation Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Change In Fair Value Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Change In Fair Value Change in fair value Change in fair value Line of credit facility minimum cash covenant. Line Of Credit Facility Minimum Cash Covenant Minimum cash covenant Commitments And Contingencies Commitments and contingencies (Note 12) Common Stock Shares Issued Common stock, shares issued U S Treasury Securities [Member] U.S. Treasury [Member] Variable Rate [Domain] Variable Rate Minimum [Member] Minimum [Member] Individuals [Axis] Individuals [Axis] Proceeds from License Fees Received License fees Debt Instrument [Axis] Debt Instrument Stockholders Equity [Abstract] Stockholders’ equity: Counterparty Name [Axis] Counterparty Name Entity Address Address Line2 Entity Address, Address Line Two Potential milestone payments upon achievement of milestone. Potential Milestone Payments Upon Achievement Of Milestone Potential milestone payments to be made Revenues [Abstract] Revenue: Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Forfeited Scenario Three. Scenario Three [Member] Not to Draw First from Tranche 2 [Member] Award Type [Axis] Award Type Other Other Other Noncash Income (Expense) Other Noncash Income (Expense), Total Subsequent Event [Member] Subsequent Event [Member] Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Unrecognized compensation expense related to stock option and RSUs Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Related Party Transaction [Domain] Related Party Transaction Trading Arr [Axis] Trading Arr [Axis] Other income (expense), net Other Nonoperating Income Expense Other Nonoperating Income (Expense), Total Other (expense) income, net: Nonoperating Income Expense [Abstract] Research And Development Expense Research and development Research and development expense Research and Development Expense, Total Development and regulaotry milestones Expenses Development and regulaotry milestones Expenses Entity Central Index Key Entity Central Index Key Short Term Investments Short-term investments Short-Term Investments, Total Net Income Loss [Abstract] Numerator—basic and diluted: Accounting Policies [Abstract] Increase Decrease In Accrued Liabilities And Other Operating Liabilities Accrued expenses and other liabilities Percentage of prepayment premium of principal amount outstanding in second year. Percentage Of Prepayment Premium Of Principal Amount Outstanding In Second Year Percentage of prepayment premium of principal amount outstanding in second year Schedule Of Available For Sale Securities [Line Items] Schedule Of Available For Sale Securities [Line Items] Two thousand fifteen omnibus incentive plan. Two Thousand Fifteen Omnibus Incentive Plan [Member] 2015 Plan [Member] UCB Biopharma. U C B Biopharma [Member] UCB Biopharma [Member] Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Stock-Based Compensation Prepaid Insurance Prepaid insurance Upfront license fees paid. Upfront License Fees Paid Up-front license fee paid General And Administrative Expense General and administrative General and Administrative Expense, Total Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals Inc [Member] Vitae Pharmaceuticals Inc [Member] Organization Consolidation And Presentation Of Financial Statements [Abstract] Incyte collaboration agreement and share purchase agreement. Incyte Collaboration Agreement And Share Purchase Agreement [Member] Incyte Collaboration Agreement and Share Purchase Agreement [Member] Research And Development Expense [Member] Research and Development [Member] Number of pre-funded warrants exchanged for common stock. Number Of Pre Funded Warrants Exchanged For Common Stock Pre-funded warrants exchange Scenario Forecast [Member] Scenario Forecast [Member] Trd Arr Adoption Date Trd Arr Adoption Date Trd Arr Adoption Date Rule 10b5-1 Arr Trmntd [Flag] Rule 10b5-1 Arr Trmntd [Flag] Rule 10b5-1 Arr Trmntd [Flag] Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Retained Earnings [Member] Accumulated Deficit [Member] Bayer Pharma AG . Bayer Pharma Ag [Member] Bayer Pharma AG [Member] Non-cash operating lease expense. Noncash Operating Lease Expense Non-cash operating lease expense At the market stock offering. At The Market Stock Offering [Member] At-the-Market Offering [Member] Accrued clinical costs current. Accrued Clinical Costs Current Accrued clinical study and trial costs Entity Interactive Data Current Entity Interactive Data Current Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number Share-based compensation, stock options vested Two thousand and seven stock incentive plan. Two Thousand And Seven Stock Incentive Plan [Member] 2007 Plan [Member] End-of Term fees Payment for end-of term fees Payment for end-of term fees Allergan license agreement. Allergan License Agreement [Member] Allergan License Agreement Member Local Phone Number Local Phone Number Collaboration receivable, net Increase Decrease In Collaboration Receivable Increase decrease in collaboration receivable. Accrued contractual obligation. Accrued Contractual Obligation Accrued contractual obligation Rule 10b5-1 Arr Adopted [Flag] Rule 10b5-1 Arr Adopted [Flag] Rule 10b5-1 Arr Adopted [Flag] Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Computation of Basic and Diluted Net Loss per Share Attributable to Common Stockholders Debt Disclosure [Abstract] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Basis of Accounting, Policy [Policy Text Block] Significant Accounting Policies Loan and security agreement. Loan And Security Agreement [Member] Loan Agreement [Member] Line Of Credit Facility [Axis] Lender Name Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Share-based compensation, stock options granted Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block] Summary of Fair Value Income Statement Location [Domain] Income Statement Location Number of pre funded warrants cashless exchanged for common stock. Number Of Pre Funded Warrants Cashless Exchanged For Common Stock Pre-funded warrants cashless exchange Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Number of Shares, Unvested, Ending balance Number of Shares, Unvested, Beginning balance Shares Outstanding Beginning balance, shares Ending balance, shares Increase Decrease In Prepaid Deferred Expense And Other Assets Prepaid expenses and other assets Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Entity Incorporation Date Of Incorporation Date of incorporation Percentage of prepayment premium of principal amount outstanding in first year. Percentage Of Prepayment Premium Of Principal Amount Outstanding In First Year Percentage of prepayment premium of principal amount outstanding in first year Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Share-based compensation, stock options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance Pre funded warrants. Pre Funded Warrants [Member] Pre Funded Warrants [Member] Fair Value Measurements [Table] Fair Value Measurements [Table] Fair Value Measurements [Table] Stock issued during period value at the market offering expenses. Stock Issued During Period Value At The Market Offering Expenses ATM Offering, offering cost Debt Instrument Name [Domain] Debt Instrument, Name Document Fiscal Year Focus Document Fiscal Year Focus Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights Vesting period, description Scenario one. Scenario One [Member] Available through April 30, 2022 [Member] Aggregate potential milestone payable. Aggregate Potential Milestone Payable Aggregate potential milestone payable Earnings Per Share Basic Net loss per share attributable to common stockholders—basic Net loss per share attributable to common stockholders—basic Earnings Per Share, Basic, Total Other Prepaid Expense Current Other Global and united states. Global And United States [Member] Global and U.S. [Member] Assets [Abstract] ASSETS Prepaid Expense And Other Assets Current Prepaid expenses and other current assets Total prepaid expenses and other current assets Shares Issued Price Per Share Purchase price per share Warrants to purchase common stock. Warrants To Purchase Common Stock [Member] Warrants to Purchase Common Stock [Member] Liabilities And Stockholders Equity [Abstract] LIABILITIES AND STOCKHOLDERS’ EQUITY Antidilutive Securities Name [Domain] Antidilutive Securities, Name Increase decrease in contractual obligation. Increase Decrease In Contractual Obligation Increase in contractual obligation Non-Refundable Cash Payments [Member] Non Refundable Cash Payments [Member] Non refundable cash payments. Profit Loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Assets Current [Abstract] Current assets: At the market equity offering sales agreement. At The Market Equity Offering Sales Agreement [Member] At The Market Equity Offering Sales Agreement [Member] Fair Value Measurements Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV Payables And Accruals [Abstract] Increase Decrease In Operating Capital [Abstract] Changes in operating assets and liabilities: Share Based Arrangements To Obtain Goods And Services [Abstract] Collaboration and license agreement allocated consideration received to derivative liability. Collaboration And License Agreement Allocated Consideration Received To Derivative Liability Allocated consideration received to derivative liability Entity [Domain] Entity Cover [Abstract] Fair Value By Measurement Basis [Axis] Measurement Basis Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Number of Shares, Vested Fair value measurements. Fair Value Measurements [Line Items] Fair Value Measurements [Line Items] Eastern Cooperative Oncology Group. Eastern Cooperative Oncology Group [Member] Eastern Cooperative Oncology Group [Member] Liabilities Current [Abstract] Current liabilities: Entity Address Address Line3 Entity Address, Address Line Three Maximum [Member] Maximum [Member] Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Unrealized gains on short-term investments Unrealized (loss) gain on marketable securities Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Share Based Compensation Expense Related to Issuance of Stock Option Awards to Employees and Non Employees Related to Employee Stock Purchase Plan Net cash provided by (used in) investing activities Net Cash Provided By Used In Investing Activities Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Number of shares, Exercised/Released Stock options exercised, shares Number of shares, Exercised/Released Stock Issued During Period Shares Stock Options Exercised Proceeds from exercise of stock options, shares Collaboration and license agreement. Collaboration And License Agreement [Member] Incyte Agreement [Member] Fair Value Inputs Level3 [Member] Significant Unobservable Inputs Level 3 [Member] Use of Estimates, Policy [Policy Text Block] Use of Estimates Debt Instrument Basis Spread On Variable Rate1 Basis spread on variable rate Stock Issued During Period Value Stock Options Exercised Proceeds from exercise of stock options Commercialization milestones and tiered royalties. Commercialization Milestones And Tiered Royalties Commercialization milestones and tiered royalties Adjustment to additional paid in capital employee withholdings employee stock purchase plan. Adjustment To Additional Paid In Capital Employee Withholdings Employee Stock Purchase Plan Employee withholdings ESPP Long-Term Investments, Total Long-Term Investments Long-term investments Collaborative research and license agreements. Collaborative Research And License Agreements [Text Block] Collaborative Research and License Agreements Common Stock Shares Authorized Common stock, shares authorized Available For Sale Securities Fair Value Disclosure [Abstract] Available For Sale Securities Fair Value Disclosure [Abstract] Trading Symbol Trading Symbol Net Income (Loss) Available to Common Stockholders, Diluted Net loss attributable to common stockholders - diluted Net loss attributable to common stockholders - diluted Schedule Of Stockholders Equity Table [Text Block] Summary of Changes in Stockholders' Equity Debt Securities Available For Sale Table [Text Block] Summary of Available-for-Sale Securities Title Of Individual With Relationship To Entity [Domain] Title of Individual Subsequent Event Type [Axis] Comprehensive Income Net Of Tax Comprehensive loss Accounts Payable Current Accounts payable Accounts Payable, Current, Total Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Unrealized Losses Plan Name [Axis] Plan Name Title Of Individual [Axis] Title of Individual Series Warrants [Member] Series Warrants [Member] Series warrants. Common Stock Par Or Stated Value Per Share Common stock, par value Collaboration receivable (payable), net Increase Decrease In Collaboration Receivable/Payable Increase Decrease In Collaboration Receivable/Payable Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Number of Shares, Granted Debt Instrument [Line Items] Debt Instrument [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Anti-dilutive securities excluded from computation of diluted net loss per common share Cash And Cash Equivalents Fair Value Disclosure Cash and cash equivalents